Targeted Protein Degradation (TPD) | Catenion Webinar Series

In this first video of the Catenion Webinar Series, learn about the landscape of Targeted Protein Degradation (TPD), a technology with disruptive potential in the biopharmaceutical industry.
• What is it? How does it work?
• What are PROTACs and molecular glues?
• Who are the key players?
• How much investment has gone into this field?
• Have TPDs been sucessful so far in clinical trials?
... and much more.
Catenion is a science-driven consulting firm for the biopharma industry. At Catenion, we leverage our science and technology expertise to develop strategies that help our clients drive innovation and bring new treatments to the market.
Follow us on LinkedIn:
/ 99993
www.catenion.com